Neuroimmunological Aberrations and Cerebral Asymmetry Abnormalities in Schizophrenia: Select Perspectives on Pathogenesis

Within the wide-ranging gamut of factors that comprise gene-environment interactions postulated to underlie schizophrenia, the crosstalk between environmental factors and feto-maternal immune components has been put forth as one of the important mechanisms that increase the risk towards schizophrenia in the offspring. Interestingly, immune factors have been shown to critically modulate the brain development during the prenatal stages. Moreover the past many decades, influential theoretical propositions and evidence base (albeit not unequivocally) have compellingly linked prenatal sex hormonal status to critically provoke long lasting immunological changes and subsequently affect developmental programming of cerebral asymmetry in schizophrenia. In this review, we summarize the select perspectives emphasizing the role of neuroimmunoendocrine pathways in anomalous cerebral asymmetry in contemporary understanding of schizophrenia pathogenesis.

[1]  Bill Bynum,et al.  Lancet , 2015, The Lancet.

[2]  Tyrone D. Cannon,et al.  The Neurodevelopmental Model of Schizophrenia: Updated , 2015 .

[3]  D. Cannon,et al.  Variation in the major histocompatibility complex [MHC] gene family in schizophrenia: Associations and functional implications , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[4]  Teruhiko Higuchi,et al.  Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorder. , 2013, Journal of psychiatric research.

[5]  I. Knuesel,et al.  Impact of Prenatal Immune System Disturbances on Brain Development , 2013, Journal of Neuroimmune Pharmacology.

[6]  V. Padmanabhan,et al.  Developmental Programming: Impact of Prenatal Testosterone Excess on Ovarian Cell Proliferation and Apoptotic Factors in Sheep1 , 2012, Biology of reproduction.

[7]  E. Fish,et al.  Sex affects immunity. , 2012, Journal of autoimmunity.

[8]  G. Dunn,et al.  Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment , 2012, Journal of psychopharmacology.

[9]  V. Padmanabhan,et al.  Developmental programming: prenatal and postnatal contribution of androgens and insulin in the reprogramming of estradiol positive feedback disruptions in prenatal testosterone-treated sheep. , 2011, Endocrinology.

[10]  J. Feldon,et al.  Schizophrenia: do all roads lead to dopamine or is this where they start? Evidence from two epidemiologically informed developmental rodent models , 2012, Translational Psychiatry.

[11]  Alan S. Brown Exposure to Prenatal Infection and Risk of Schizophrenia , 2011, Front. Psychiatry.

[12]  B. Kirkpatrick,et al.  Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects , 2011, Biological Psychiatry.

[13]  Jean-Francois Mangin,et al.  A robust cerebral asymmetry in the infant brain: The rightward superior temporal sulcus , 2011, NeuroImage.

[14]  P. Patterson,et al.  Activation of the maternal immune system induces endocrine changes in the placenta via IL-6 , 2011, Brain, Behavior, and Immunity.

[15]  K. Nuechterlein,et al.  Distinct neural generators of sensory gating in schizophrenia. , 2011, Psychophysiology.

[16]  P. Buckley,et al.  Brain-derived neurotrophic factor: findings in schizophrenia , 2011, Current opinion in psychiatry.

[17]  P. Fitzgerald,et al.  Estrogens and men with schizophrenia: Is there a case for adjunctive therapy? , 2011, Schizophrenia Research.

[18]  P. Nikolova,et al.  Season of birth, Geschwind and Galaburda hypothesis, and handedness , 2011, Laterality.

[19]  A. Wagner,et al.  The hippocampal formation in schizophrenia. , 2010, The American journal of psychiatry.

[20]  X. Wang,et al.  Estrogen receptor alpha and G-protein coupled receptor 30 mediate the neuroprotective effects of 17β-estradiol in novel murine hippocampal cell models , 2010, Neuroscience.

[21]  L. Price,et al.  Association between Plasma IL-6 Response to Acute Stress and Early-Life Adversity in Healthy Adults , 2010, Neuropsychopharmacology.

[22]  P. Fitzgerald,et al.  Piloting the effective therapeutic dose of adjunctive selective estrogen receptor modulator treatment in postmenopausal women with schizophrenia , 2010, Psychoneuroendocrinology.

[23]  A. Salminen,et al.  Influence of selective estrogen receptor modulators on interleukin-6 expression in human retinal pigment epithelial cells (ARPE-19). , 2010, European journal of pharmacology.

[24]  K. Hashimoto Abnormality of cerebral perfusion in the posterior cingulate gyrus of a refractory patient with schizophrenia and minocycline treatment , 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[25]  A. McAllister,et al.  Novel Roles for Immune Molecules in Neural Development: Implications for Neurodevelopmental Disorders , 2010, Front. Syn. Neurosci..

[26]  J. Kowalski,et al.  Functional Polymorphism in the Interleukin-6 and Interleukin-10 Genes in Patients with Paranoid Schizophrenia —A Case-Control Study , 2010, Journal of Molecular Neuroscience.

[27]  B. Castellano,et al.  Ontogeny of sensorimotor gating and immune impairment induced by prenatal immune challenge in rats: implications for the etiopathology of schizophrenia , 2010, Molecular Psychiatry.

[28]  Alan S. Brown,et al.  Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. , 2010, The American journal of psychiatry.

[29]  V. van de Ven,et al.  Reduced Laterality as a Trait Marker ofSchizophrenia—Evidence from Structural and Functional Neuroimaging , 2010, The Journal of Neuroscience.

[30]  Y. Levkovitz,et al.  A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia. , 2010, The Journal of clinical psychiatry.

[31]  Rudi A. Dierckx,et al.  Neuroinflammation in Schizophrenia-Related Psychosis: A PET Study , 2009, Journal of Nuclear Medicine.

[32]  Michael I. Miller,et al.  Neuroanatomical asymmetry patterns in individuals with schizophrenia and their non-psychotic siblings , 2009, NeuroImage.

[33]  J. Feldon,et al.  A review of the fetal brain cytokine imbalance hypothesis of schizophrenia. , 2009, Schizophrenia bulletin.

[34]  S. Bilbo,et al.  Early-Life Programming of Later-Life Brain and Behavior: A Critical Role for the Immune System , 2009, Front. Behav. Neurosci..

[35]  Takahiro A. Kato,et al.  Cytokines and schizophrenia: Microglia hypothesis of schizophrenia , 2009, Psychiatry and clinical neurosciences.

[36]  H. Son,et al.  Adult hippocampal neurogenesis and related neurotrophic factors. , 2009, BMB reports.

[37]  A. Roberts,et al.  IL-6 Mediated Degeneration of Forebrain GABAergic Interneurons and Cognitive Impairment in Aged Mice through Activation of Neuronal NADPH Oxidase , 2009, PloS one.

[38]  T. Landis,et al.  Anomalous brain dominance and the immune system: Do left-handers have specific immunological patterns? , 2009, Brain and Cognition.

[39]  M. Behrens,et al.  Interleukin-6 Mediates the Increase in NADPH-Oxidase in the Ketamine Model of Schizophrenia , 2008, The Journal of Neuroscience.

[40]  M. Keshavan,et al.  Schizophrenia, “just the facts”: What we know in 2008 Part 3: Neurobiology , 2008, Schizophrenia Research.

[41]  T. Crow,et al.  Auditory cortex asymmetry, altered minicolumn spacing and absence of ageing effects in schizophrenia. , 2008, Brain : a journal of neurology.

[42]  B. Barres The Mystery and Magic of Glia: A Perspective on Their Roles in Health and Disease , 2008, Neuron.

[43]  K. Hashimoto Microglial activation in schizophrenia and minocycline treatment , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[44]  Ahmad R. Hariri,et al.  Interleukin-6 Covaries Inversely with Hippocampal Grey Matter Volume in Middle-Aged Adults , 2008, Biological Psychiatry.

[45]  S Marenco,et al.  Serious obstetric complications interact with hypoxia-regulated/vascular-expression genes to influence schizophrenia risk , 2008, Molecular Psychiatry.

[46]  M. Bailey,et al.  Estrogen in severe mental illness: a potential new treatment approach. , 2008, Archives of general psychiatry.

[47]  T. Crow The ʻbig bangʼ theory of the origin of psychosis and the faculty of language , 2008, Schizophrenia Research.

[48]  Shi-Hao Wu,et al.  [Estrogen protects the dopaminergic neurons in substantia nigra against damage induced by 6-hydroxydopamine]. , 2008, Sheng li xue bao : [Acta physiologica Sinica].

[49]  R. Doty,et al.  Estrogen replacement therapy induces functional asymmetry on an odor memory/discrimination test , 2008, Brain Research.

[50]  Emmanuel Stip,et al.  Inflammatory Cytokine Alterations in Schizophrenia: A Systematic Quantitative Review , 2008, Biological Psychiatry.

[51]  Nash N. Boutros,et al.  P50 sensory gating ratios in schizophrenics and controls: A review and data analysis , 2008, Psychiatry Research.

[52]  Yuko Fujita,et al.  Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[53]  P. Patterson,et al.  Maternal Effects on Schizophrenia Risk , 2007, Science.

[54]  K. Mirnics,et al.  Maternal Immune Activation Alters Fetal Brain Development through Interleukin-6 , 2007, The Journal of Neuroscience.

[55]  G. Venkatasubramanian,et al.  Insulin and insulin-like growth factor-1 abnormalities in antipsychotic-naive schizophrenia. , 2007, The American journal of psychiatry.

[56]  D. Brann,et al.  Neurotrophic and neuroprotective actions of estrogen: Basic mechanisms and clinical implications , 2007, Steroids.

[57]  F. Kirchhoff,et al.  Glia: the fulcrum of brain diseases , 2007, Cell Death and Differentiation.

[58]  L. Lee,et al.  Maternal antibrain antibodies in autism , 2007, Brain, Behavior, and Immunity.

[59]  S. Bauer,et al.  The neuropoietic cytokine family in development, plasticity, disease and injury , 2007, Nature Reviews Neuroscience.

[60]  Jing Chen,et al.  Interleukin-6 Facilitates Lipopolysaccharide-Induced Disruption in Working Memory and Expression of Other Proinflammatory Cytokines in Hippocampal Neuronal Cell Layers , 2006, The Journal of Neuroscience.

[61]  M. Ross,et al.  Maternal N-acetylcysteine suppresses fetal inflammatory cytokine responses to maternal lipopolysaccharide. , 2006, American journal of obstetrics and gynecology.

[62]  I. Sargent,et al.  NK cells and human pregnancy--an inflammatory view. , 2006, Trends in immunology.

[63]  H. Kinney,et al.  Development of microglia in the cerebral white matter of the human fetus and infant , 2006, The Journal of comparative neurology.

[64]  B. Bogerts,et al.  Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization , 2006, Acta Neuropathologica.

[65]  H. Hansson,et al.  Prenatal exposure to interleukin-6 results in inflammatory neurodegeneration in hippocampus with NMDA/GABA(A) dysregulation and impaired spatial learning. , 2006, American journal of physiology. Regulatory, integrative and comparative physiology.

[66]  Alan S. Brown,et al.  Prenatal infection as a risk factor for schizophrenia. , 2006, Schizophrenia bulletin.

[67]  J. Feldon,et al.  Prenatal and postnatal maternal contributions in the infection model of schizophrenia , 2006, Experimental Brain Research.

[68]  T. Crow,et al.  Minicolumn thinning in temporal lobe association cortex but not primary auditory cortex in normal human ageing , 2006, Acta Neuropathologica.

[69]  E. Peeva,et al.  Spotlight on the role of hormonal factors in the emergence of autoreactive B-lymphocytes. , 2005, Immunology letters.

[70]  Ann Summerfelt,et al.  Review of clinical correlates of P50 sensory gating abnormalities in patients with schizophrenia. , 2005, Schizophrenia bulletin.

[71]  T. Groothuis,et al.  Prenatal androgen exposure modulates cellular and humoral immune function of black-headed gull chicks , 2005, Proceedings of the Royal Society B: Biological Sciences.

[72]  J. Kwon,et al.  Asymmetry analysis of deformable hippocampal model using the principal component in schizophrenia , 2005, Human brain mapping.

[73]  G. Hammond,et al.  Handedness in schizophrenia: a quantitative review of evidence , 2005, Acta psychiatrica Scandinavica.

[74]  Abraham Weizman,et al.  The possible role of neurotrophins in the pathogenesis and therapy of schizophrenia , 2005, European Neuropsychopharmacology.

[75]  J L Rapoport,et al.  The neurodevelopmental model of schizophrenia: update 2005 , 2005, Molecular Psychiatry.

[76]  D. Kalaitzidis,et al.  Transcription factor cross-talk: the estrogen receptor and NF-κB , 2005, Trends in Endocrinology & Metabolism.

[77]  T. Lang Estrogen as an immunomodulator. , 2004, Clinical immunology.

[78]  A. Meyer-Lindenberg,et al.  The Brain-derived Neurotrophic Factor Val66met Polymorphism and Variation in Human Cortical Morphology , 2022 .

[79]  Stephan Heckers,et al.  The hippocampus in schizophrenia. , 2004, The American journal of psychiatry.

[80]  Paul J. Harrison The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications , 2004, Psychopharmacology.

[81]  T. Crow Cerebral asymmetry and the lateralization of language: core deficits in schizophrenia as pointers to the gene , 2004 .

[82]  N. Kato,et al.  What causes seasonality of birth in schizophrenia? , 2004, Neuroscience Research.

[83]  J. Borrell,et al.  Prenatal Immune Challenge Disrupts Sensorimotor Gating in Adult Rats: Implications for the Etiopathogenesis of Schizophrenia , 2002, Neuropsychopharmacology.

[84]  Jean K. Moore,et al.  Cytoarchitectural and Axonal Maturation in Human Auditory Cortex , 2001, Journal of the Association for Research in Otolaryngology.

[85]  W. Hopkins,et al.  Asymmetric Broca's area in great apes , 2001, Nature.

[86]  D. Buxhoeveden,et al.  Lateralization of Minicolumns in Human Planum temporale Is Absent in Nonhuman Primate Cortex , 2001, Brain, Behavior and Evolution.

[87]  N. Weekes,et al.  Handedness and immune function , 2001, Brain and Cognition.

[88]  R. McCarley,et al.  A review of MRI findings in schizophrenia , 2001, Schizophrenia Research.

[89]  R. Kahn,et al.  Handedness, language lateralisation and anatomical asymmetry in schizophrenia: meta-analysis. , 2001, The British journal of psychiatry : the journal of mental science.

[90]  D. Kaplan,et al.  Reciprocal actions of interleukin‐6 and brain‐derived neurotrophic factor on rat and mouse primary sensory neurons , 2000, The European journal of neuroscience.

[91]  F. Chiarelli,et al.  Interleukin-6 release by cultured peripheral blood mononuclear cells inversely correlates with height velocity, bone age, insulin-like growth factor-I, and insulin-like growth factor binding protein-3 serum levels in children with perinatal HIV-1 infection. , 2000, Clinical immunology.

[92]  P. Fitzgerald,et al.  Estrogen — a potential treatment for schizophrenia , 2000, Schizophrenia Research.

[93]  J S Yudkin,et al.  The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. , 1998, The Journal of clinical investigation.

[94]  Geoff Sanders,et al.  Verbal and music dichotic listening tasks reveal variations in functional cerebral asymmetry across the menstrual cycle that are phase and task dependent , 1998, Neuropsychologia.

[95]  A. Braun,et al.  Asymmetry of chimpanzee planum temporale: humanlike pattern of Wernicke's brain language area homolog. , 1998, Science.

[96]  T. Crow Is schizophrenia the price that Homo sapiens pays for language? , 1997, Schizophrenia Research.

[97]  S. Doré,et al.  Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[98]  D. Kimura Sex, sexual orientation and sex hormones influence human cognitive function , 1996, Current Opinion in Neurobiology.

[99]  S. Denburg,et al.  Evaluating the Empirical Support for the Role of Testosterone in the Geschwind-Behan-Galaburda Model of Cerebral Lateralization - Commentary , 1995, Brain and Cognition.

[100]  M. Hassler,et al.  Functional brain organization, handedness, and immune vulnerability in musicians and non-musicians , 1993, Neuropsychologia.

[101]  B. Rabin,et al.  The prevalence of autoantibodies among right and left handed schizophrenic patients and control subjects , 1992, Biological Psychiatry.

[102]  B. Rabin,et al.  Left-handed first-episode, neuroleptic-naive schizophrenic patients have a higher prevalence of autoantibodies , 1992, Schizophrenia Research.

[103]  P. Neveu Asymmetrical brain modulation of the immune response , 1992, Brain Research Reviews.

[104]  R. E. Wheeler,et al.  Frontal brain asymmetry and immune function. , 1991, Behavioral neuroscience.

[105]  B. Rabin,et al.  Handedness and autoantibodies , 1991, The Lancet.

[106]  M. Bryden,et al.  Geschwind's theory of cerebral lateralization: developing a formal, causal model. , 1991, Psychological bulletin.

[107]  M. Meyers,et al.  For better or for worse: left-handedness, pathology, and talent. , 1989, Journal of clinical and experimental neuropsychology.

[108]  A. Searleman,et al.  Suspected autoimmune disorders and left-handedness: Evidence from individuals with diabetes, Crohn's disease and ulcerative colitis , 1987, Neuropsychologia.

[109]  J. R. Hughes Cerebral lateralization: biological mechanisms, associations and pathology , 1987 .

[110]  M. Haith,et al.  Left-handedness and immune disorders in familial dyslexics. , 1987, Archives of neurology.

[111]  N. Geschwind,et al.  Cerebral lateralization. Biological mechanisms, associations, and pathology: I. A hypothesis and a program for research. , 1985, Archives of neurology.

[112]  N. Geschwind,et al.  Left-handedness: association with immune disease, migraine, and developmental learning disorder. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[113]  P. Venables,et al.  Selectivity of attention, withdrawal, and cortical activation. Studies in chronic schizophrenia. , 1963, Archives of general psychiatry.

[114]  A. Kiev Disorders of Attention and Perception in Early Schizophrenia , 1962 .

[115]  A. Mcghie,et al.  Disorders of attention and perception in early schizophrenia. , 1961, The British journal of medical psychology.

[116]  G. Venkatasubramanian,et al.  Successful use of add-on minocycline for treatment of persistent negative symptoms in schizophrenia. , 2013, The Journal of neuropsychiatry and clinical neurosciences.

[117]  Z. Daskalakis,et al.  The role of BDNF in the pathophysiology and treatment of schizophrenia. , 2012, Journal of psychiatric research.

[118]  P. Nikolova,et al.  Brain asymmetry, immunity, handedness , 2011 .

[119]  P. Patterson,et al.  Neuroscience. Maternal effects on schizophrenia risk. , 2007, Science.

[120]  I. Sargent,et al.  Immunoregulation in normal pregnancy and pre-eclampsia: an overview. , 2007, Reproductive biomedicine online.

[121]  S. Poole,et al.  The role of cytokines in mediating effects of prenatal infection on the fetus: implications for schizophrenia , 2006, Molecular Psychiatry.

[122]  D. Kalaitzidis,et al.  Transcription factor cross-talk: the estrogen receptor and NF-kappaB. , 2005, Trends in endocrinology and metabolism: TEM.

[123]  B. Schmidt-Sidor,et al.  Degeneration of microglial cells in frontal and temporal lobes of chronic schizophrenics. , 2004, Folia neuropathologica.

[124]  P. Satz,et al.  Atypical handedness in schizophrenia: some methodological and theoretical issues. , 1999, Schizophrenia bulletin.

[125]  M. Hassler Anomalous dominance, immune parameters, and spatial ability. , 1993, The International journal of neuroscience.

[126]  N. Geschwind,et al.  Cerebral lateralization. Biological mechanisms, associations, and pathology: III. A hypothesis and a program for research. , 1985, Archives of neurology.

[127]  N. Geschwind,et al.  Cerebral lateralization. Biological mechanisms, associations, and pathology: II. A hypothesis and a program for research. , 1985, Archives of neurology.